Annalise Enterprise CTB Triage-OH

by Annalise.ai  · Based in Australia → — Empowering clinicians to make accurate, faster decisions with AI-powered medical imaging solutions.
Emergency Medicine Neurology Radiology

On request
Regulatory Status Disclosed

Overview

Annalise Enterprise CTB Triage-OH is a medical device software application that utilizes an artificial intelligence (AI) algorithm to identify suspected obstructive hydrocephalus (OH) findings in non-contrast computed tomography (NCCT) brain scans. This software workflow tool is designed to aid in the triage and prioritization of radiological medical images, making study-level output available to an order and imaging management system for worklist prioritization or triage. The device employs a convolutional neural network trained using deep-learning techniques on extensive datasets, including over 200,000 CT brain imaging studies, annotated by qualified radiologists. It provides both passive and active notifications for suspected OHCP cases, enabling clinicians to review critical studies earlier in the workflow without decreasing the existing priority of other studies. Annalise Enterprise CTB Triage-OH is intended for adjunctive use by trained clinicians qualified to interpret brain CT studies, enhancing diagnostic accuracy and efficiency in radiology and emergency care settings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered obstructive hydrocephalus detection
  • Non-contrast brain CT analysis
  • Worklist prioritization and triage
  • Passive and active notifications
  • Convolutional neural network algorithm
  • Deep learning techniques
  • Compatible with PACS/RIS
  • Aids in diagnostic accuracy
  • Enhances workflow efficiency
  • Supports rapid clinical decision-making

Use Cases

  • Triage and prioritization of non-contrast brain CT studies
  • Early detection of obstructive hydrocephalus
  • Improving diagnostic accuracy in radiology departments
  • Accelerating critical interventions in emergency care
  • Optimizing radiology workflow
  • Providing a 'second set of eyes' for radiologists

What Physicians Need to Know

Brain MRI/CT Analysis
Annalise Enterprise CTB Triage-OH is a software-based triage tool for non-contrast brain CT studies. It uses a deep-learning convolutional neural network to detect obstructive hydrocephalus (OH) and can identify up to 130 findings on unenhanced CT brain scans. The device is designed to aid in the triage and prioritization of studies with features suggestive of OH in non-contrast CT (NCCT) brain scans for patients 22 years or older. It analyzes studies using an AI algorithm to identify findings and makes study-level output available to an order and imaging management system for worklist prioritization or triage. The device does not highlight specific image regions; it provides study-level triage only. It has demonstrated sensitivity ranging from 88.1% to 97.6% and specificity from 94.0% to 97.0% for obstructive hydrocephalus. It can detect up to 130 findings, including intracranial hemorrhage, hematomas (acute subdural/extradural), fractures, pneumocephalus, infarct, mass effect & midline shift, obstructive hydrocephalus, intraaxial mass, transependymal oedema, colloid cyst, and vasogenic oedema. The tool highlights the location of specific findings with a colored outline and indicates the model's confidence in detected findings. It can display findings in sagittal, axial, and coronal projections, and within five pre-set windows (subdural, bone, brain, soft tissue, and stroke windows).
Large Vessel Occlusion Detection
While the Annalise Enterprise CTB Triage-OH is primarily focused on obstructive hydrocephalus, the broader Annalise Enterprise CTB solution has been shown to outperform other AI solutions in infarct and hemorrhage detection. The use of AI algorithms to triage and prioritize head CT cases with large vessel occlusion or intracranial hemorrhage is well established. However, the Annalise Enterprise CTB Triage-OH specifically focuses on obstructive hydrocephalus.
Triage Prioritization Speed
The device has a triage effectiveness (turn-around time) of 81.6 seconds (95% CI: 80.3-82.9) on a dataset of 277 cases. It ingests DICOM images from PACS/RIS, processes them, and outputs a notification to the imaging management system to prioritize the study in the clinician's worklist. The device operates in parallel to standard clinical workflows and never downgrades existing worklist priority. It enables earlier review of urgent studies, potentially improving clinical turnaround times and patient outcomes. It provides both passive and active notifications for suspected obstructive hydrocephalus cases identified on unenhanced head CT scans. The AI-generated worklists expedite critical cases automatically, leading to faster diagnoses for urgent medical conditions.
Mobile Notification System
Annalise.ai's solution enables both passive and active notifications for suspected obstructive hydrocephalus cases identified on unenhanced head CT scans. The device identifies studies with selected findings and communicates these studies to the worklist software, which enables triaging of the worklist and notification. It can also send an active notification to the clinical team (neurologists, neuroradiologists, radiologists, and emergency physicians) to begin care coordination.
Physician Tip

Annalise Enterprise CTB Triage-OH is a valuable tool for prioritizing non-contrast brain CT studies, particularly for suspected obstructive hydrocephalus. It can significantly reduce turnaround times for urgent cases and improve diagnostic accuracy for a wide range of findings. However, it is crucial to remember that this is a triage and notification tool, not a diagnostic device. Clinicians must always review the AI output concurrently with the original images and all other relevant clinical information before making a clinical decision. The tool's ability to detect up to 130 findings on unenhanced CT brain scans can act as a 'second pair of eyes,' potentially reducing missed critical findings. The customizable sensitivity/specificity settings and finding order can be tailored to specific clinical workflows.

Annalise Enterprise CTB Triage-OH seamlessly integrates directly within RIS/PACS and can be launched from either platform. It ingests DICOM images from PACS/RIS and outputs a notification to the imaging management system for worklist prioritization or triage. Results are displayed as DICOM Secondary Captures alongside the patient's original images. AI results can be used to support the prioritization of the worklist. The Worklist Triage can be integrated via HL7 or an API. It is compatible with image and order management systems such as picture archiving and communication systems (PACS) and radiological information systems (RIS). The device has been validated on images from Toshiba, GE, Siemens, Philips, and Canon scanners.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing On request
DeploymentWeb, Cloud, On-premise
Mobile AppIOS, Android
API Available Yes
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2023-08-15K231094 510(k)Annalise Enterprise CTB Triage-OH

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Annalise Enterprise CTB Triage-OH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Annalise Enterprise CTB Triage-OH.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Annalise Enterprise CTB Triage-OH is an AI-powered software tool designed to aid in the triage and prioritization of non-contrast brain CT studies for suspected obstructive hydrocephalus (OH) in patients 22 years or older. It analyzes CT scans using a deep-learning convolutional neural network to identify findings suggestive of OH and then makes this study-level output available to an order and imaging management system to prioritize the study in the clinician's worklist. This helps to expedite the review process for potentially life-threatening conditions.
Annalise Enterprise CTB Triage-OH is a Class II medical device that has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). It also holds the FDA Breakthrough Device Designation, which is granted to technologies that provide more effective treatment or diagnosis for life-threatening or debilitating conditions. The device is intended for prescription use and is designed to be used by trained clinicians qualified to interpret brain CT studies.
Annalise Enterprise CTB Triage-OH is intended to aid in the prioritization and triage of radiological medical images only. It is not intended for standalone clinical decision-making, to rule out a specific finding, or to replace the clinical assessment of CT brain studies. The device provides study-level triage and notification for suspected findings but does not highlight specific image regions or direct users' attention to a particular location in the original image.
While Annalise Enterprise CTB Triage-OH is a specialized AI solution for obstructive hydrocephalus, other AI-powered tools exist for different neurological findings on non-contrast CT brain studies. Annalise.ai also offers Annalise Enterprise CTB, which is a comprehensive decision-support AI solution capable of detecting up to 130 findings on non-contrast head CT studies, including various intracranial hemorrhages and mass effect. Other companies offer various healthcare software solutions, but direct alternatives specifically for AI-driven obstructive hydrocephalus triage from other vendors are not explicitly detailed in the provided information.
Hospitals acquire the Annalise Enterprise CTB Triage-OH system on a subscription-based model, with an estimated annual cost of $180,000 per hospital. Additionally, the Centers for Medicare and Medicaid Services (CMS) will provide a new technology add-on payment (NTAP) of approximately $241.39 for cases using the triage software, starting in 2025.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Annalise.ai

Annalise Enterprise CXR Triage Trauma
Annalise.ai
Radiology & Imaging AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-03 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.